Companies ›Healthcare ›HLX.MI

HLX.MI — Borsa Italiana Biotechnology & Medical Research

Helyx Industries S.P.A.

€0,73

Open in Charts → Attach watcher ⌖

— —

EUR

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

19,0M EUR

P/E

—

EV / Rev

—

Div yield

—

Op margin

-227,5 %

ROE

-21,9 %

Net margin

-228,5 %

Debt / equity

0,05

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

2026-10-28

Ex-dividend

—

TR 1Y

—

About

HLX.MI operates in the healthcare diagnostics sector, focusing on biotechnology and medical research, and generates revenue primarily through the development and sale of diagnostic products and services.

Business. HLX.MI is a healthcare diagnostics company operating within the biotechnology and medical research industry. The firm is headquartered in Italy and is primarily listed on the Borsa Italiana under the ticker HLX.MI. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %

SectorHealthcare

Business sectorPharmaceuticals & Medical Research

IndustryBiotechnology & Medical Research

ActivityHealthcare Diagnostics

Generated · model-assisted

Sell-side consensus

BUY1 analysts

1 buy0 hold0 sell

Avg 12m price target1,49

Analyst recommendations

1 analysts · consensus Buy

Buy1

Hold0

Sell0

12-month price target

1,49

Consensus of sell-side coverage.

Upcoming events

EarningsQ3 2026 earnings (expected)2026-10-28 · estimated

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts→

Buy

1 analysts · indicative

Ownership→

American Century Investment Management, Inc.

largest disclosed fund holder

Profitability→

-21,9 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning HLX.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to HLX.MI. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Company
EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

HLX.MI is a healthcare diagnostics company operating within the biotechnology and medical research industry. The firm is headquartered in Italy and is primarily listed on the Borsa Italiana under the ticker HLX.MI. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %

SectorHealthcare

Business sectorPharmaceuticals & Medical Research

IndustryBiotechnology & Medical Research

ActivityHealthcare Diagnostics

AI synthesis

GENERATED

HLX.MI exhibits a low liquidity risk, with a current ratio of 2.76 and a cash and equivalents balance of 1,261,730 EUR, which is relatively modest compared to its total assets of 23,994,290 EUR. The company's price-to-book ratio of 0.92 suggests that the market values the company slightly below its book value, indicating potential undervaluation or financial distress.

Profitability metrics for HLX.MI are concerning, with a return on equity of -0.2195 and a return on assets of -0.184, both significantly below industry norms. The company reported a net loss of 4,415,920 EUR, and its operating income was also negative at -4,396,430 EUR, reflecting poor operational performance.

The company's revenue is concentrated in a single segment, as disclosed in its financials, with no specific geographic breakdown provided. This lack of diversification could pose a risk if the company's primary market experiences a downturn.

HLX.MI's growth trajectory is uncertain, with no clear indication of revenue growth in the current or next fiscal year. The company's operating cash flow is negative at -1,751,350 EUR, and its free cash flow is also negative at -1,575,070 EUR, suggesting that it is not generating sufficient cash to sustain operations or fund growth.

Risk factors for HLX.MI include a low liquidity risk and a low dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company's debt-to-equity ratio of 0.05 indicates a conservative capital structure, but its negative operating and free cash flows could impact its ability to service debt in the future.

Recent events for HLX.MI include analyst estimates that suggest a mean price target of 1.49 EUR, with a strong-buy recommendation from one analyst. However, the company's financial performance and market valuation do not currently support such optimism.

Key takeaways

HLX.MI is a biotechnology and medical research company with a focus on healthcare diagnostics.
The company is currently experiencing significant financial losses, with a net loss of 4,415,920 EUR.
HLX.MI's liquidity position is relatively stable, with a current ratio of 2.76 and a cash and equivalents balance of 1,261,730 EUR.
The company's profitability metrics are poor, with a return on equity of -0.2195 and a return on assets of -0.184.
Analysts have a positive outlook on HLX.MI, with a mean price target of 1.49 EUR and a strong-buy recommendation.

Bull / Bear case

Generated · model-assisted

— missing data

In focus — financials by report

Valuation

Market price

€0,73

Market cap

€18.5M

Enterprise valueⓘ

€18.3M

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

0.9x

P / Tangible bookⓘ

0.9x

Tangible book

€20.1M

Net cashⓘ

€236.0k

Current ratioⓘ

2.8

Debt / equityⓘ

0.1

ROAⓘ

-18.4%

ROEⓘ

-21.9%

Cash conversionⓘ

40.0%

CapEx / revenueⓘ

-7.5%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

Business relationships49 disclosed relationships · 2 types · extracted from filings & disclosures

Customers2

SHELL PLCSHEL.LCustomer95%Source ↗

Talos Energy IncTALO.KCustomer95%Source ↗

Subsidiaries47

EX21:005f584b63ddEX21:005f584b63ddSubsidiarie97%

EX21:0714e4c3cd91EX21:0714e4c3cd91Subsidiarie97%

EX21:0c98d1091141EX21:0c98d1091141Subsidiarie97%

EX21:0cabd23920a7EX21:0cabd23920a7Subsidiarie97%

EX21:0fad4086241fEX21:0fad4086241fSubsidiarie97%

EX21:11c60f9c28b6EX21:11c60f9c28b6Subsidiarie97%

EX21:15b5e5ef6493EX21:15b5e5ef6493Subsidiarie97%

EX21:1c7dcc59b3b0EX21:1c7dcc59b3b0Subsidiarie97%

EX21:20904acd6e59EX21:20904acd6e59Subsidiarie97%

EX21:21da2c1b3e74EX21:21da2c1b3e74Subsidiarie97%

EX21:23fac573405fEX21:23fac573405fSubsidiarie97%

EX21:274bd9f096dcEX21:274bd9f096dcSubsidiarie97%

EX21:290d39684418EX21:290d39684418Subsidiarie97%

EX21:302e274dc0d2EX21:302e274dc0d2Subsidiarie97%

EX21:34020e080826EX21:34020e080826Subsidiarie97%

EX21:372bc956fc22EX21:372bc956fc22Subsidiarie97%

EX21:3b17a8cf35afEX21:3b17a8cf35afSubsidiarie97%

EX21:41cf5b1385e3EX21:41cf5b1385e3Subsidiarie97%

EX21:46deca0a94c9EX21:46deca0a94c9Subsidiarie97%

EX21:49ea061c38ffEX21:49ea061c38ffSubsidiarie97%

EX21:4b66fc026514EX21:4b66fc026514Subsidiarie97%

EX21:4b99b3da5646EX21:4b99b3da5646Subsidiarie97%

EX21:5aa9f27a91d3EX21:5aa9f27a91d3Subsidiarie97%

EX21:5b123b8e46b8EX21:5b123b8e46b8Subsidiarie97%

EX21:5bdb72a3b838EX21:5bdb72a3b838Subsidiarie97%

EX21:617060f51794EX21:617060f51794Subsidiarie97%

EX21:6c24c82f236cEX21:6c24c82f236cSubsidiarie97%

EX21:74f73cb699f2EX21:74f73cb699f2Subsidiarie97%

EX21:87fbe4524a54EX21:87fbe4524a54Subsidiarie97%

EX21:9776ca701ebeEX21:9776ca701ebeSubsidiarie97%

EX21:a1c25c79ca5bEX21:a1c25c79ca5bSubsidiarie97%

EX21:a2b7c07e5f11EX21:a2b7c07e5f11Subsidiarie97%

EX21:b705fbb324c7EX21:b705fbb324c7Subsidiarie97%

EX21:be9ca3172f43EX21:be9ca3172f43Subsidiarie97%

EX21:c0ba1d4421f5EX21:c0ba1d4421f5Subsidiarie97%

EX21:c248f8ce7f72EX21:c248f8ce7f72Subsidiarie97%

EX21:c2716c92cd1fEX21:c2716c92cd1fSubsidiarie97%

EX21:c60ea79304e5EX21:c60ea79304e5Subsidiarie97%

EX21:c98f12344676EX21:c98f12344676Subsidiarie97%

EX21:d205ff5410f2EX21:d205ff5410f2Subsidiarie97%

EX21:d31baa5dd672EX21:d31baa5dd672Subsidiarie97%

EX21:d81a9aa10984EX21:d81a9aa10984Subsidiarie97%

EX21:e43c5a4640adEX21:e43c5a4640adSubsidiarie97%

EX21:e4cf35b717bbEX21:e4cf35b717bbSubsidiarie97%

EX21:ede1078d2974EX21:ede1078d2974Subsidiarie97%

EX21:fd3f85b5a1d6EX21:fd3f85b5a1d6Subsidiarie97%

EX21:ff800c7da09cEX21:ff800c7da09cSubsidiarie97%

Supply chain

Vendors → HLX ↔ Partners → Customers · click any node to drill

2 mentions in 10-K0 from corporate websites0 from news dispatches

Updated 2026-06-24

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Next quarternear-term

Earnings · next quarterconf 45 %

EPS

Consensus EPS

-0,03

Predicted surprise

+0,00

Beat probability

45 %

Analysts

Other metrics

Revenue

—

no estimate

Segment revenue

—

no estimate

Margin

—

no estimate

Segment margin

—

no estimate

as of 2026-05-04 · Earnings Surprise V1

Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.

Full fiscal year~1 year ahead

Full fiscal year · our forecast vs guidance vs consensus

Metric	Our forecast	Guidance	Consensus
EPS	—no estimate	—no estimate	-0,03
Revenue	—no estimate	—no estimate	2,0M EUR
Operating income	—no estimate	—no estimate	-1,0M EUR

Full-year consensus mean (period as reported by source) · consensus in EUR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.

Probabilistic model output — not investment advice. · generated 2026-08-04

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Consensus distribution

sell-side coverage

Recommendation distribution1 analysts

Strong buy1

Buy0

Hold0

Sell0

Strong sell0

12-month price target€1,49 · Median €1,49

Low €1,49High €1,49

Operating income · consensus-1,0M EUR

EPS surprise

−429,4 %

reported vs consensus · miss

Revenue surprise

−30,0 %

reported vs consensus · miss

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

Low€1,49

Mean€1,49

Median€1,49

High€1,49

Spot€0,73

+104.1 %implied to mean12-month sell-side price targets · ▲ spot

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskLow

Filing-based flags

No immediate filing-based liquidity or dilution flags were detected.

Benchmarks vs cohort

Op Margin-227,5 %Below median

Net Margin-228,5 %Below median

ROE-21,9 %Below median

Capex / Rev-7,5 %Above median

D/E0,05Below median

Cash Conv0,40Bottom quartile

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

Derivative transactions

Net acquired 680 163 sh19 exercises · 9 grants5 insiders

KRATZ OWEN EDirector, PRESIDENT & CEO · Performance Share Units → Common StockDisposed 368 292exercise · 2026-02-26
Sparks Scott AndrewEVP & COO · Performance Share Units → Common StockDisposed 140 667exercise · 2026-02-26
Staffeldt ErikEVP & CFO · Performance Share Units → Common StockDisposed 132 995exercise · 2026-02-26
Neikirk Kenneth EnglishEVP, GEN COUNSEL & SECRETARY · Performance Share Units → Common StockDisposed 97 188exercise · 2026-02-26
Arriaga Brent AlexanderVP and CAO · Restricted Stock Units → Common StockDisposed 5 646exercise · 2026-01-03
Sparks Scott AndrewEVP & COO · Restricted Stock Units → Common StockDisposed 31 053exercise · 2026-01-03
Staffeldt ErikEVP & CFO · Restricted Stock Units → Common StockDisposed 29 359exercise · 2026-01-03
Neikirk Kenneth EnglishEVP, GEN COUNSEL & SECRETARY · Restricted Stock Units → Common StockDisposed 21 455exercise · 2026-01-03
KRATZ OWEN EDirector, PRESIDENT & CEO · Restricted Stock Units → Common StockDisposed 81 301exercise · 2026-01-03
KRATZ OWEN EDirector, PRESIDENT & CEO · Restricted Stock Units → Common StockAcquired 287 081grant · 2026-01-01
Neikirk Kenneth EnglishEVP, GEN COUNSEL & SECRETARY · Restricted Stock Units → Common StockDisposed 15 402exercise · 2026-01-01
Neikirk Kenneth EnglishEVP, GEN COUNSEL & SECRETARY · Restricted Stock Units → Common StockDisposed 16 988exercise · 2026-01-01
Neikirk Kenneth EnglishEVP, GEN COUNSEL & SECRETARY · Restricted Stock Units → Common StockAcquired 83 732grant · 2026-01-01
Neikirk Kenneth EnglishEVP, GEN COUNSEL & SECRETARY · Performance Share Units → Common StockAcquired 167 464grant · 2026-01-01
Staffeldt ErikEVP & CFO · Restricted Stock Units → Common StockDisposed 21 077exercise · 2026-01-01
Staffeldt ErikEVP & CFO · Restricted Stock Units → Common StockDisposed 26 466exercise · 2026-01-01
Staffeldt ErikEVP & CFO · Restricted Stock Units → Common StockAcquired 125 199grant · 2026-01-01
Staffeldt ErikEVP & CFO · Performance Share Units → Common StockAcquired 250 398grant · 2026-01-01
Sparks Scott AndrewEVP & COO · Restricted Stock Units → Common StockDisposed 22 292exercise · 2026-01-01
Sparks Scott AndrewEVP & COO · Restricted Stock Units → Common StockDisposed 24 588exercise · 2026-01-01
Sparks Scott AndrewEVP & COO · Restricted Stock Units → Common StockAcquired 109 649grant · 2026-01-01
Sparks Scott AndrewEVP & COO · Performance Share Units → Common StockAcquired 219 298grant · 2026-01-01
KRATZ OWEN EDirector, PRESIDENT & CEO · Restricted Stock Units → Common StockDisposed 58 366exercise · 2026-01-01
KRATZ OWEN EDirector, PRESIDENT & CEO · Restricted Stock Units → Common StockDisposed 64 377exercise · 2026-01-01
KRATZ OWEN EDirector, PRESIDENT & CEO · Performance Share Units → Common StockAcquired 574 162grant · 2026-01-01

Physical assets

23 tracked

Asset	Type	Commodity	Country	Role
ASKHOLMEN	Vessel	—	English Channel, UK Continent Tanker Zone	Manager
DALLAS	Vessel	—	Gulf of Mexico	Registered owner
DALLAS	Vessel	—	Gulf of Mexico	Manager
EXPLORER	Vessel	—	Gulf of Mexico	Manager
EXPLORER	Vessel	—	Gulf of Mexico	Registered owner
FURUHOLMEN	Vessel	—	Gulf of Mexico, US Gulf Tanker Zone	Manager
HELIX PRODUCER 1	Vessel	—	Gulf of Mexico, United States	Manager
JASMINA D.	Vessel	—	Hebei, Far East Bulker Zone, East China Sea, China (Mainland)	Manager
JULIETTA D	Vessel	—	South East Asia Bulker Zone, Gulf of Thailand, Thailand	Manager
KIRKEHOLMEN	Vessel	Naphtha	English Channel, UK Continent Tanker Zone	Manager
MARYAM D	Vessel	—	Far East Bulker Zone, East China Sea	Manager
MEREL D	Vessel	—	West Coast South America Bulker Zone, Pacific Ocean (Central America)	Manager
MIAMI	Vessel	—	Gulf of Mexico, United States	Manager
MIAMI	Vessel	—	Gulf of Mexico, United States	Registered owner
Q4000	Vessel	—	Gulf of Mexico	Registered owner
Q4000	Vessel	—	Gulf of Mexico	Manager
SEAWELL	Vessel	—	North Sea	Manager
SEAWELL	Vessel	—	North Sea	Registered owner
SUZANNA D	Vessel	—	West Coast Central America Bulker Zone, Pacific Ocean (Central America), Panama Canal Waypoint	Manager
TRITON CRUSADER	Vessel	—	Gulf of Mexico	Registered owner
TRITON CRUSADER	Vessel	—	Gulf of Mexico	Manager
WELL ENHANCER	Vessel	—	North Sea, United Kingdom	Registered owner
WELL ENHANCER	Vessel	—	North Sea, United Kingdom	Manager

Tracked physical assets associated with this issuer (operated, managed, or owned).

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Return On Equity
net_income / total_equity
Price To Book
market_price / (adjusted_book_value / shares_outstanding_diluted)
Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Market Price
input from market-data provider (delayed close or quote-shim mid)
Market Cap
market_price * shares_outstanding_diluted
Ev To Revenue
enterprise_value / revenue

Source documents

HLX.MI Market data — financials · 2026-05-28
Helyx Industries SpA Market data — analyst estimates · 2026-05-28

Ownership & reference

Top holders

American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,03 %$51M
Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,02 %$45M
Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,02 %$89M
Invesco QQQ TrustFunds · as of 2026-03-310,01 %$66M
Wellington Management Company, LLPInvestment Managers · as of 2026-03-310,01 %$39M
BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,01 %$278M
JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,01 %$10M
Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$26M
Arrowstreet Capital, Limited PartnershipInvestment Managers · as of 2026-03-310,00 %$6M
Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$21M
State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$66M
Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$17M
Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$33M
Nuveen LLCInvestment Managers · as of 2024-12-310,00 %$7M
Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$8M
Victory Capital Management Inc.Investment Managers · as of 2026-03-310,00 %$2M
Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$82M
Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$20M
AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$5M
Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,00 %$4M
AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,00 %$2M
UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$4M
FMR LLCInstitutional Investor · as of 2026-03-310,00 %$5M
AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$1M
PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M
Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,00 %$1M
T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M
Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$1M
LPL Financial LLCInvestment Managers · as of 2026-03-310,00 %$0M
JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$0M

Insider activity

Net selling0 buys · 1 sellsnet -$275K8 insiders · last 365d

Arriaga Brent AlexanderVP and CAO · Common StockOther 2 521 @ $6,40$16K · 2026-01-03
Arriaga Brent AlexanderVP and CAO · Common StockOther 5 646 · 2026-01-03
Arriaga Brent AlexanderVP and CAO · Common StockOther 4 053 · 2026-01-01
Arriaga Brent AlexanderVP and CAO · Common StockOther 1 810 @ $6,27$11K · 2026-01-01
Arriaga Brent AlexanderVP and CAO · Common StockOther 7 153 · 2026-01-01
Arriaga Brent AlexanderVP and CAO · Common StockOther 3 194 @ $6,27$20K · 2026-01-01
Harris PaulaDirector · Common StockOther 3 274 @ $7,25$24K · 2025-12-11
Little Thomas MitchellDirector · Common StockOther 4 762 @ $7,25$35K · 2025-12-11
Nelson Amy HDirector · Common StockOther 5 506 @ $7,25$40K · 2025-12-11
TRANSIER WILLIAM LDirector · Common StockOther 5 506 @ $7,25$40K · 2025-12-11
Glassman DianaDirector · Common StockOther 20 690 · 2025-12-10
Harris PaulaDirector · Common StockOther 20 690 · 2025-12-10
Little Thomas MitchellDirector · Common StockOther 20 690 · 2025-12-10
LOVOI JOHNDirector · Common StockOther 20 690 · 2025-12-10
TRANSIER WILLIAM LDirector · Common StockOther 20 690 · 2025-12-10
Nelson Amy HDirector · Common StockOther 20 690 · 2025-12-10
Sparks Scott AndrewEVP & COO · Common StockSold 40 000 @ $6,88$275K · 2025-11-03

Short positioning

7.3Mshares short+1.1% vs prior

5.63days to cover

54.8%short of daily vol

657fails-to-deliver

as of 2026-07-15 · short-interest report (free)

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

HLX.MICanonical

Borsa Italiana · EUR

Intel & risk

PredictorBeat prob45 %Surprise+0,00Full forecast →

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskLow

No immediate filing-based liquidity or dilution flags were detected.

Relationship graph

This companySectorCustomersSubsidiaries

Evidence & claims

From filings & derived data

EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -43.2%Derived (calculated)
EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -41.7%Derived (calculated)
Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 21.0%Derived (calculated)
Debt-to-equity (FY 2025-12-31): 0.66xDerived (calculated)
Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 4.0%Derived (calculated)
Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): -0.6%Derived (calculated)
Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -3.8%Derived (calculated)
Total assets (YoY) (2025-12-31 vs 2024-12-31): 0.7%Derived (calculated)
Operating income (YoY) (2025-12-31 vs 2024-12-31): -48.9%Derived (calculated)
Revenue (YoY) (2025-12-31 vs 2024-12-31): -4.9%Derived (calculated)
Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -26.5%Derived (calculated)
Net income (YoY) (2025-12-31 vs 2024-12-31): -44.6%Derived (calculated)
Long-term debt (YoY) (2025-12-31 vs 2024-12-31): -2.3%Derived (calculated)
Gross profit (YoY) (2025-12-31 vs 2024-12-31): -27.5%Derived (calculated)
Net margin (FY 2025-12-31): 2.4%Derived (calculated)
Gross margin (FY 2025-12-31): 12.3%Derived (calculated)
Return on equity (FY 2025-12-31): 2.0%Derived (calculated)
Return on assets (FY 2025-12-31): 1.2%Derived (calculated)
Current ratio (FY 2025-12-31): 2.75xDerived (calculated)
Gross profit (annual): USD 159.14MSEC XBRL filing
Cost of revenue (annual): USD 1.13BSEC XBRL filing
Operating income (annual): USD 65.14MSEC XBRL filing
EPS (basic) (annual): USD-PER-SHARES 0SEC XBRL filing
EPS (diluted) (annual): USD-PER-SHARES 0SEC XBRL filing

Showing 24 of 60 surfaced claims.

Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

The Thread

Everything we know, in order

2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date

2026-07-29 00:00 UTCTRANSCRIPTEarnings call — Q3 2026

2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)

2026-06-12FILING8-K filing →

2026-05-13FILING8-K filing →

2026-05-05FILING8-K filing →

2026-04-24FILING10-Q filing →

2026-04-24FILING8-K filing →

2026-04-23FILING8-K filing →

2026-04-01FILINGDEF 14A filing →

2026-02-26 00:00 UTCINSIDER4 insider transactions — 2026-02 4 derivative

2026-02-26FILING10-K filing →

2026-02-26INSIDERNeikirk Kenneth English disposed of 97.2k sh Performance Share Units — EVP, GEN COUNSEL & SECRETARY

2026-02-26INSIDERSparks Scott Andrew disposed of 140.7k sh Performance Share Units — EVP & COO

2026-02-26INSIDERStaffeldt Erik disposed of 133.0k sh Performance Share Units — EVP & CFO

2026-02-26INSIDERKRATZ OWEN E disposed of 368.3k sh Performance Share Units — Director, PRESIDENT & CEO

2026-02-24FILING8-K filing →

2026-02-13FILING8-K filing →

2026-01-03 00:00 UTCINSIDER30 insider transactions — 2026-01 24 derivative

2026-01-03INSIDERArriaga Brent Alexander transacted 2.5k sh — VP and CAO ~$16k

2026-01-03INSIDERArriaga Brent Alexander transacted 5.6k sh — VP and CAO

2026-01-03INSIDERArriaga Brent Alexander disposed of 5.6k sh Restricted Stock Units — VP and CAO

2026-01-03INSIDERKRATZ OWEN E disposed of 81.3k sh Restricted Stock Units — Director, PRESIDENT & CEO

2026-01-03INSIDERSparks Scott Andrew disposed of 31.1k sh Restricted Stock Units — EVP & COO

2026-01-03INSIDERStaffeldt Erik disposed of 29.4k sh Restricted Stock Units — EVP & CFO

2026-01-03INSIDERNeikirk Kenneth English disposed of 21.5k sh Restricted Stock Units — EVP, GEN COUNSEL & SECRETARY

2026-01-01INSIDERArriaga Brent Alexander transacted 4.1k sh — VP and CAO

2026-01-01INSIDERArriaga Brent Alexander transacted 1.8k sh — VP and CAO ~$11k

2026-01-01INSIDERArriaga Brent Alexander transacted 7.2k sh — VP and CAO

2026-01-01INSIDERArriaga Brent Alexander transacted 3.2k sh — VP and CAO ~$20k

2026-01-01INSIDERSparks Scott Andrew disposed of 24.6k sh Restricted Stock Units — EVP & COO

2026-01-01INSIDERSparks Scott Andrew acquired 109.6k sh Restricted Stock Units — EVP & COO

2026-01-01INSIDERKRATZ OWEN E disposed of 58.4k sh Restricted Stock Units — Director, PRESIDENT & CEO

2026-01-01INSIDERKRATZ OWEN E disposed of 64.4k sh Restricted Stock Units — Director, PRESIDENT & CEO

2026-01-01INSIDERKRATZ OWEN E acquired 287.1k sh Restricted Stock Units — Director, PRESIDENT & CEO

2026-01-01INSIDERKRATZ OWEN E acquired 574.2k sh Performance Share Units — Director, PRESIDENT & CEO

2026-01-01INSIDERSparks Scott Andrew acquired 219.3k sh Performance Share Units — EVP & COO

2026-01-01INSIDERNeikirk Kenneth English disposed of 15.4k sh Restricted Stock Units — EVP, GEN COUNSEL & SECRETARY

2026-01-01INSIDERNeikirk Kenneth English disposed of 17.0k sh Restricted Stock Units — EVP, GEN COUNSEL & SECRETARY

Showing the 40 most recent of 61 entries.

The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

Analyst recommendations

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Consensus distribution

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Derivative transactions

Physical assets

Actions

Ask Handelsavisen

Ownership & reference

Top holders

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread